Literature DB >> 20636707

Relationship between serum lipid values and atherosclerotic burden in the proximal thoracic aorta.

Shun Kohsaka1, Zhezhen Jin, Tatjana Rundek, Shunichi Homma, Ralph L Sacco, Marco R Di Tullio.   

Abstract

BACKGROUND: We conducted a cross-sectional analysis in a population-based cohort to compare the strength of the associations among various lipid parameters and the presence of atherosclerotic plaque in the proximal thoracic aorta.
METHODS: As part of Aortic Plaques and Risk of Ischemic Stroke (APRIS) study, 464 subjects were studied (mean age 69.1 +/- 9.0, 251 males and 213 females), including 255 patients with first ischaemic stroke and 209 stroke-free controls. Presence and thickness of atherosclerotic plaque were assessed by transoesophageal echocardiography. Measured lipid parameters included total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol, lipoprotein (a), apolipoprotein (Apo) B and A-I levels with their ratio.
RESULTS: Overall, atherosclerotic plaque was detected in 326 subjects (70.4%) and 37.6% of these subjects (n=174) had atherosclerotic plaque > or =4 mm. After adjusting for other significant predictors of atherosclerosis, high-density lipoprotein cholesterol level and Apo B/A-I ratio emerged as the strongest predictors of any atherosclerotic plaque (P<0.001 and P=0.004, respectively), followed by individual Apo B (P=0.015) and A-I (P=0.016) levels, triglycerides (P=0.027) and non-high-density lipoprotein cholesterol level (P=0.021). Total and low-density lipoprotein cholesterol levels were not significant predictors for any atherosclerotic plaque (P=0.273 and P=0.081, respectively). High-density lipoprotein cholesterol level (P=0.008) and Apo A-I (P=0.006) were also significant predictors of atherosclerotic plaque > or =4 mm. Similar trends were observed after exclusion of subjects on cholesterol lowering drugs.
CONCLUSION: High-density lipoprotein cholesterol level and Apo B/A-I ratio, but not total or low-density lipoprotein cholesterol levels, were strongly associated with degree of proximal aortic atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636707      PMCID: PMC2907532          DOI: 10.1111/j.1747-4949.2010.00437.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  40 in total

1.  Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: the tromsø study.

Authors:  E B Mathiesen; K H Bønaa; O Joakimsen
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

2.  Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population.

Authors:  M R Di Tullio; R L Sacco; M T Savoia; R R Sciacca; S Homma
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

Review 3.  Risk factor thresholds: their existence under scrutiny.

Authors:  M R Law; N J Wald
Journal:  BMJ       Date:  2002-06-29

4.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

Authors:  G Walldius; I Jungner; I Holme; A H Aastveit; W Kolar; E Steiner
Journal:  Lancet       Date:  2001-12-15       Impact factor: 79.321

5.  Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients.

Authors:  Souvik Sen; Stephen M Oppenheimer; Joao Lima; Barry Cohen
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

6.  Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke.

Authors:  Shigeru Fujimoto; Masahiro Yasaka; Ryoichi Otsubo; Hiroshi Oe; Kazuyuki Nagatsuka; Kazuo Minematsu
Journal:  Stroke       Date:  2004-04-29       Impact factor: 7.914

7.  Aortic arch plaques and risk of recurrent stroke and death.

Authors:  Marco R Di Tullio; Cesare Russo; Zhezhen Jin; Ralph L Sacco; J P Mohr; Shunichi Homma
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

8.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

9.  Echolucent, rupture-prone carotid plaques associated with elevated triglyceride-rich lipoproteins, particularly in women.

Authors:  Steen Christian Kofoed; Marie-Louise Moes Grønholdt; Jean Bismuth; Jens E Wilhjelm; Henrik Sillesen; Børge G Nordestgaard
Journal:  J Vasc Surg       Date:  2002-10       Impact factor: 4.268

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

View more
  1 in total

1.  Alcohol consumption and atherosclerotic burden in the proximal thoracic aorta.

Authors:  Shun Kohsaka; Zhezhen Jin; Tatjana Rundek; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  Atherosclerosis       Date:  2011-08-16       Impact factor: 5.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.